Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
- 1 April 1991
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (7), 2936-2940
- https://doi.org/10.1073/pnas.88.7.2936
Abstract
The osteoclast is unique in its ability to resorb bone, and excessive osteoclastic activity has been implicated in osteoporosis, Paget disease of bone, rheumatoid arthritis, and the growth of metastases in bone. The activity of this cell is controlled by the main circulating inhibitor, calcitonin, in association with locally produced modulators. We show that nitric oxide (NO) may be an important member of the latter group. NO is produced by the vascular endothelium and nervous system and is involved in both neurotransmission and the regulation of blood pressure. However, our results show that the autocoid is also a potent inhibitor of osteoclast function. NO (30 microM) produced a decrease to approximately 50% of the original osteoclast spread area. Similar effects were also produced by 3-morpholinosydnonimine or sodium nitroprusside, reagents that spontaneously release NO. These shape changes were associated with a reduction of bone resorption after a 24-hr incubation of isolated osteoclasts on devitalized bone slices. NO is thought to act by stimulating guanylate cyclase, with a consequent increase in cyclic GMP, but a different mode of action is likely in the osteoclast since dibutyryl or 8-bromo cyclic GMP have no effect. It should be noted that calcitonin can produce similar changes in shape and activity but is associated with an increase in osteoclast intracellular calcium and cessation of membrane movement; neither of these is produced by NO, suggesting that its mode of action is different. The abundance of NO-producing endothelial cells in bone marrow and their proximity to osteoclasts suggests that marrow endothelial cells may play a physiological role in the regulation of osteoclastic activity.Keywords
This publication has 20 references indexed in Scilit:
- Modularity of osteoclast behaviour and “mode-specific” inhibition of osteoclast functionBioscience Reports, 1990
- Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathwaysJournal of Endocrinology, 1990
- Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALBc 3T3 fibroblasts by a cyclic GMP-independent mechanismBiochemical and Biophysical Research Communications, 1990
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.JCI Insight, 1990
- EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.Proceedings of the National Academy of Sciences, 1990
- Intracellular calcium in the control of osteoclast function I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazemBiochemical and Biophysical Research Communications, 1990
- The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclastsBioscience Reports, 1989
- ‘Calcium-activated’ intracellular calcium elevation: A novel mechanism of osteoclast regulationBiochemical and Biophysical Research Communications, 1989
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987